share_log

Joinn Laboratories(China)Co.Ltd's (SHSE:603127) Soft Earnings Don't Show The Whole Picture

Joinn Laboratories(China)Co.Ltd's (SHSE:603127) Soft Earnings Don't Show The Whole Picture

昭和实验室(中国)有限公司(SHSE: 603127)的软收益并未显示全貌
Simply Wall St ·  04/08 02:33

The market for Joinn Laboratories(China)Co.,Ltd.'s (SHSE:603127) shares didn't move much after it posted weak earnings recently. We did some digging, and we believe the earnings are stronger than they seem.

Joinn Laboratories(中国)有限公司的市场, Ltd. 's(上海证券交易所股票代码:603127)在最近公布疲软的收益后,股价没有太大波动。我们进行了一些挖掘,我们认为收益比看起来要强劲。

earnings-and-revenue-history
SHSE:603127 Earnings and Revenue History April 8th 2024
SHSE: 603127 2024 年 4 月 8 日的收益和收入历史记录

The Impact Of Unusual Items On Profit

不寻常物品对利润的影响

For anyone who wants to understand Joinn Laboratories(China)Co.Ltd's profit beyond the statutory numbers, it's important to note that during the last twelve months statutory profit was reduced by CN¥227m due to unusual items. While deductions due to unusual items are disappointing in the first instance, there is a silver lining. When we analysed the vast majority of listed companies worldwide, we found that significant unusual items are often not repeated. And that's hardly a surprise given these line items are considered unusual. Assuming those unusual expenses don't come up again, we'd therefore expect Joinn Laboratories(China)Co.Ltd to produce a higher profit next year, all else being equal.

对于任何想了解Joinn Laboratories(中国)有限公司超出法定数字的利润的人来说,值得注意的是,在过去的十二个月中,由于异常项目,法定利润减少了2.27亿元人民币。尽管由于不寻常项目而产生的扣除首先令人失望,但有一线希望。当我们分析全球绝大多数上市公司时,我们发现重大不寻常的事项往往不会重演。鉴于这些单列项目被认为不寻常,这并不奇怪。假设这些不寻常的支出不会再次出现,因此,我们预计卓能实验室(中国)有限公司在其他条件相同的情况下,明年将实现更高的利润。

That might leave you wondering what analysts are forecasting in terms of future profitability. Luckily, you can click here to see an interactive graph depicting future profitability, based on their estimates.

这可能会让你想知道分析师对未来盈利能力的预测。幸运的是,您可以单击此处查看根据他们的估计描绘未来盈利能力的交互式图表。

Our Take On Joinn Laboratories(China)Co.Ltd's Profit Performance

我们对卓能制药(中国)有限公司的盈利表现的看法

Unusual items (expenses) detracted from Joinn Laboratories(China)Co.Ltd's earnings over the last year, but we might see an improvement next year. Because of this, we think Joinn Laboratories(China)Co.Ltd's earnings potential is at least as good as it seems, and maybe even better! And we are pleased to note that EPS is at least heading in the right direction over the last three years. The goal of this article has been to assess how well we can rely on the statutory earnings to reflect the company's potential, but there is plenty more to consider. If you'd like to know more about Joinn Laboratories(China)Co.Ltd as a business, it's important to be aware of any risks it's facing. While conducting our analysis, we found that Joinn Laboratories(China)Co.Ltd has 3 warning signs and it would be unwise to ignore them.

不寻常的项目(支出)减少了卓能实验室(中国)有限公司去年的收益,但明年我们可能会看到改善。正因为如此,我们认为卓能实验室(中国)有限公司的盈利潜力至少和看上去一样好,甚至可能更好!我们高兴地注意到,在过去三年中,每股收益至少朝着正确的方向发展。本文的目标是评估我们在多大程度上可以依靠法定收益来反映公司的潜力,但还有很多需要考虑的地方。如果您想进一步了解Joinn Laboratories(中国)有限公司的业务,请务必了解其面临的任何风险。在进行分析时,我们发现Joinn Laboratories(中国)有限公司有3个警告标志,忽视它们是不明智的。

This note has only looked at a single factor that sheds light on the nature of Joinn Laboratories(China)Co.Ltd's profit. But there are plenty of other ways to inform your opinion of a company. For example, many people consider a high return on equity as an indication of favorable business economics, while others like to 'follow the money' and search out stocks that insiders are buying. So you may wish to see this free collection of companies boasting high return on equity, or this list of stocks that insiders are buying.

本报告仅研究了揭示Joinn Laboratories(中国)有限公司利润性质的单一因素。但是,还有很多其他方法可以让你对公司的看法。例如,许多人认为高股本回报率是有利的商业经济的标志,而另一些人则喜欢 “关注资金”,寻找内部人士正在买入的股票。因此,你可能希望看到这份免费收藏的拥有高股本回报率的公司,或者这份内部人士正在购买的股票清单。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

对这篇文章有反馈吗?对内容感到担忧?直接联系我们。 或者,给编辑团队 (at) simplywallst.com 发送电子邮件。
Simply Wall St的这篇文章本质上是笼统的。我们仅使用公正的方法根据历史数据和分析师的预测提供评论,我们的文章无意作为财务建议。它不构成买入或卖出任何股票的建议,也没有考虑到您的目标或财务状况。我们的目标是为您提供由基本数据驱动的长期重点分析。请注意,我们的分析可能不考虑最新的价格敏感型公司公告或定性材料。简而言之,华尔街没有持有任何上述股票的头寸。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发